RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System
September 24 2019 - 7:05AM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, today announced the full commercial launch of the
CervAlign® Anterior Cervical Plate (ACP) System to add to the
growth of its Established Therapies spine portfolio.
The CervAlign ACP System is designed to promote cervical fusion
by providing temporary resistance to flexion, extension, lateral
bending and axial rotation with strength and stiffness in the
cervical spine (C2-C7). The system includes implants of various
plate and screw sizes to accommodate varying patient anatomies. It
also helps reduce complexity for the surgeon customer with an
integrated cover-style locking mechanism that adds zero profile,
streamlined instrumentation with the same driver for screws, pins,
locking and revisions, and low-profile plates ranging from one to
five levels, each with large graft windows for intraoperative
visibility. Additionally, using the Fortilink®-C Interbody Fusion
(IBF) System with TETRAfuse® 3D Technology and ViBone® Viable Bone
Matrix with the CervAlign ACP provides surgeons a complete anterior
cervical discectomy and fusion (ACDF) solution.
“The locking mechanism on the CervAlign ACP System is easily
visible and engaged, and there is no guesswork as to whether it is
completely locked,” said Franco E. Vigna, MD, MPH, FACOS of
reVive Spine Center in Buffalo, New York. “Additionally, the amount
of screw angulation allows for use of a shorter plate. Combined
with the large graft windows and visibility of the plate, it allows
surgeons to easily instrument the hard-to-access levels such as
C3.”
The CervAlign ACP System is intended for anterior cervical
fixation (C2-C7) for the following conditions: degenerative disc
disease (DDD) defined as neck pain of discogenic origin with
degeneration of the disc confirmed by history and radiographic
studies, spondylolisthesis, trauma (e.g., fracture or dislocation),
spinal stenosis, deformities or curvatures (e.g., scoliosis,
kyphosis, and/or lordosis), tumor, pseudarthrosis and failed
previous fusion.
“After a successful Limited Market Release, we are excited to
commercially launch the CervAlign ACP system to offer a plate with
a cover-style locking mechanism and streamlined instrumentation,”
said Camille Farhat, President and CEO. “This is a great example of
how we plan to use home-grown innovation to accelerate our spine
business. CervAlign ACP adds another option for surgeons in our
current Established Therapies portfolio, which we have recently
reinvigorated through our R&D efforts across hardware,
interbodies and biologics. As we further accelerate growth in
spine, we will be able to meet the demands of more surgeons and
treat more patients.”
About RTI Surgical Holdings, Inc.
RTI Surgical is a leading global surgical implant company
providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in spine, sports medicine, general surgery, orthopedic and
trauma procedures and are distributed in nearly 50 countries. RTI
has four manufacturing facilities throughout the U.S. and Europe.
RTI is accredited in the U.S. by the American Association of Tissue
Banks and is a member of AdvaMed. For more information, visit
www.rtix.com. Connect with us
on LinkedIn and Twitter.
Molly Poarch Investor Contact mpoarch@rtix.com
+1 224 287 2661
Steven Cohen Media Contact scohen@rtix.com +1
847 648 0861
Forward-Looking Statements
Portions of this document may constitute “forward-looking
statements” as defined by federal law. Although the company
believes any such statements are based on reasonable assumptions,
there is no assurance that actual outcomes will not be materially
different. Any such statements are made in reliance on the “safe
harbor” protections provided under the Private Securities Reform
Act of 1995. Additional information about issues that could lead to
material changes in performance is contained in the company’s
annual and quarterly reports filed with the Securities and Exchange
Commission.
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Sep 2023 to Sep 2024